ArticleJournal of ovarian research2021

UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway.

Wenjing Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.